Crystalline forms of aliskiren hemifumarate

Details for Australian Patent Application No. 2007323465 (hide)

Owner Novartis AG

Inventors Monnier, Stephanie; Stowasser, Frank

Agent Davies Collison Cave

Pub. Number AU-B-2007323465

PCT Pub. Number WO2008/061622

Priority 06123642.8 07.11.06 EP

Filing date 5 November 2007

Wipo publication date 29 May 2008

Acceptance publication date 4 August 2011

International Classifications

C07C 237/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/061622 Priority application(s): WO2008/061622

4 August 2011 Application Accepted

  Published as AU-B-2007323465

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323468-Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye

2007323432-Manual breast pump